CLOMIPHENE CITRATE
Clomiphene Allergy
rana alaaeldin aly ibrahim nasrSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Clomiphene Allergy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Qinggongshoutao Bolus Dongzhimen Hospital, Beijing | Phase 4 | BB |
Ginkgo Biloba Extract Dongzhimen Hospital, Beijing | Phase 4 | BB |
Thalidomide Chang Gung Memorial Hospital | Phase 2 | B |
(1-(2-tetrahydrofuryl)-5-fluorouracil) and uracil 1:4 Chang Gung Memorial Hospital | Phase 2 | B |
LAMOTRIGINE Seoul National University Hospital | Phase 2 | CCC |
View all 17 →
Same molecule, other indications
CLOMIPHENE CITRATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →